Halitron, Inc. HAON – Commences $60 million Acquisition Pipeline $3-5 Sales Projected Next 12 Months

Miami, FL -- July 7, 2016 -- InvestorsHub NewsWire -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Halitron, Inc. (OTC Pink: HAON)
 
Halitron, Inc. (OTC Pink: HAON) Today announced that it Commenced its Growth Plan Projecting Sales of $3M+
 
See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
http://emerginggrowth.com/?s=haon
 
Halitron (OTC Pink: HAON) Halitron is well positioned for sales and profit growth in 2016.
 
The company stated in its release earlier today “We are now forecasting sales to grow from $1.2 million in 2015 to $3 - $5 million in sales over the next 12 months as we commence our growth plan towards our $60M in sales acquisition pipeline working closely with new and larger financial partners to help support the evaluation, due diligence, and potential closing process.”
 
With HAON’s Recent announcement discussing a 75% increase in sales, and $3 - $5 million in increased growth, HAON may not be at these levels much longer. 
 
One of Halitron Inc.’s (OTC Pink: HAON) business units is vertically integrated with manufacturing located just over the border of San Diego, CA. It consists of four niche branded sales outlets in the US marketing scrapbooking, archiving, and printed products servicing businesses and consumers totaling over 400,000 customers.
 
 
Other Companies in the news and featured on EmergingGrowth.com
 
Premier Biomedical, Inc.  
Biomedical and research company, Premier Biomedical, Inc. (OTCQB: BIEI) jumped 33% in early trading on Wednesday, July 06, 2016. The healthcare company has experienced average daily volume of around 2.4 million shares over the past three months. However, nearly 4.41 million shares or $82,467 in dollar volume has exchanged hands in the early hours of trading.
 
The big news out of Premier Biomedical, Inc. (OTCQB: BIEI) detailed an update on the company’s anti-cancer antibody, PBI-5D3H5, which showed to have more favorable results in testing on mice. In other words, the initial testing showed that Premier Biomedical, Inc. (OTCQB: BIEI)’s cancer antibody is more effective than traditional cancer treatment options. Here is the full story on EmergingGrowth.com: http://emerginggrowth.com/premier-biomedical-inc-otcqb-biei-rallies-33-anti-cancer-treatment-testing/
 
 
BTCS, Inc.
We reported on BTCS, Inc. (OTCQB: BTCS) during the last week of June.  Nothing has changed except the most recent 8K filed yesterday which states: Over the course of June 22, 2016 through July 5, 2016, BTCS Inc. (the “Company”) issued a total of 37,820,911 shares of the Company’s common stock (the “Common Stock”) for: i) the conversion of $37,500 of principal and accrued interest on the Senior Secured Convertible Notes issued December 16, 2015 (the “Notes”), and ii) the exercise of warrants. The issuances were exempt from registration pursuant to Rule 506 under Regulation D, the investors are sophisticated and familiar with our operations, and there was no solicitation in connection with the issuances.

I guess that explains it. 
 
SPO Global, Inc.
SPO Global, Inc. (OTC Pink: SPOM) spiked yesterday trading almost double its previous volume high of arounc 40 million shares.
 
The stock was up 50% on nothing that we have seen to date.  Somebody is in the know.  SPO (SOFTWARE PERFORMANCE OPTIMIZATION) GLOBAL INC, is an emerging technology company that is focused on selling its unique performance testing optimization and monitoring software IP for all enterprise applications.
 
About EmergingGrowth.com
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space. 
 
Disclosure:
All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-4266/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.
 
CONTACT:
Company: EmergingGrowth.com - http://www.EmergingGrowth.com
Contact Email: [e-mail]
SOURCE: EmergingGrowth.com